Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Formative Research

Date Submitted: Jan 22, 2026
Date Accepted: Jul 8, 2026

The final, peer-reviewed published version of this preprint can be found here:

Efficacy of a Remote Person-Centered Intervention Using an eHealth Platform and Telephone Support for Persons With Chronic Pain: Randomized Controlled Trial

Lundin Ã, Lilja V, Ekman I, Andréll P, Lundberg M, Saarijärvi M, Segertoft VA, Goudarzi M, Fors A, Wallström S

Efficacy of a Remote Person-Centered Intervention Using an eHealth Platform and Telephone Support for Persons With Chronic Pain: Randomized Controlled Trial

JMIR Form Res 2026;10:e91887

DOI: 10.2196/91887

PMID: 42546261

Efficacy of a Remote Person-centred Intervention Using an eHealth Platform and Telephone Support for Persons with Chronic Pain: A Randomized Controlled Trial

  • Ã…se Lundin; 
  • Veronica Lilja; 
  • Inger Ekman; 
  • Paulin Andréll; 
  • Mari Lundberg; 
  • Markus Saarijärvi; 
  • Vivi-Anne Segertoft; 
  • Mahboubeh Goudarzi; 
  • Andreas Fors; 
  • Sara Wallström

ABSTRACT

Background:

Chronic pain is a growing global public health challenge, and the leading cause of years lived with disability. It significantly impacts various aspects of life, including participation in working life. Person-centred care (PCC) has been shown in other studies to improve self-efficacy and facilitate return to work. However, the efficacy of PCC in persons on sick leave due to chronic pain remains largely unexplored.

Objective:

To evaluate the efficacy of a person-centred intervention at home, consisting of a combined telephone support and eHealth platform, in persons on sick leave due to chronic pain.

Methods:

A two-armed, non-blinded randomized controlled trial was conducted. Both groups received usual care; the intervention group additionally participated in a PCC intervention via telephone and an eHealth platform. The primary outcome was a composite score consisting of change in general self-efficacy and self-reported sick leave at 6-month follow-up.

Results:

A total of 59 participants were randomized to the intervention (n=29) and control group (n=30). More participants in the control group (n=11, 38.7%) than in the intervention group (n=3, 10.3%) showed deterioration, resulting in a significant difference in the composite score between the groups at the 6-month follow-up (P=.037) favouring the intervention.

Conclusions:

This study suggests that PCC via telephone and an eHealth platform may influence the sick leave level and self-efficacy in persons with chronic pain. Since the control group deteriorated while the intervention group largely remained unchanged, PCC may play a protective role in supporting persons with chronic pain in returning to work. Further studies are warranted to confirm the findings. Clinical Trial: ClinicalTrials.gov identifier: NCT04706195, submitted 2021-01-09. URL: https://clinicaltrials.gov/study/NCT04706195?term=eaper&rank=


 Citation

Please cite as:

Lundin Ã, Lilja V, Ekman I, Andréll P, Lundberg M, Saarijärvi M, Segertoft VA, Goudarzi M, Fors A, Wallström S

Efficacy of a Remote Person-Centered Intervention Using an eHealth Platform and Telephone Support for Persons With Chronic Pain: Randomized Controlled Trial

JMIR Form Res 2026;10:e91887

DOI: 10.2196/91887

PMID: 42546261

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.